The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial

Christophe Langouët-Astrié1, Kaori Oshima1, Sarah A McMurtry1

  • 1Division of Pulmonary Sciences and Critical Care, University of Colorado Denver, Aurora, CO 80045, USA.

Cell Reports
|November 30, 2022
PubMed

Insights

Secondary pneumonia from methicillin-resistant Staphylococcus aureus (MRSA) complicates influenza. The influenza-injured lung environment alters MRSA

Area of Science:

  • Microbiology and Immunology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Secondary bacterial pneumonia, particularly methicillin-resistant Staphylococcus aureus (MRSA), significantly exacerbates influenza infections.
  • The complex interplay between the influenza-damaged lung environment and MRSA pathogenesis remains incompletely understood.
  • Understanding these host-pathogen interactions is crucial for developing effective treatments for severe post-influenza complications.

Purpose of the Study:

  • To investigate the bidirectional interactions between the influenza-injured lung microenvironment and MRSA.
  • To elucidate the mechanisms by which influenza infection influences MRSA virulence and adaptation.
  • To identify key bacterial factors and host molecules involved in the severity of post-influenza MRSA pneumonia.

Main Methods:

  • MRSA was cultured ex vivo in bronchoalveolar lavage fluid from influenza-infected mice at different time points.
  • Changes in MRSA gene expression, cytotoxin production, and metabolic activity were analyzed.
  • The role of the LukAB cytotoxin and its interaction with host heparan sulfate (HS) was examined.

Main Results:

  • The influenza-injured lung microenvironment induced MRSA to upregulate cytotoxin expression, notably LukAB.
  • Metabolic pathways in MRSA were suppressed by the host environment.
  • LukAB activity was enhanced by heparan sulfate (HS) fragments shed from the lung epithelium post-influenza, increasing MRSA virulence.

Conclusions:

  • Post-influenza MRSA pneumonia is driven by a dynamic, bidirectional interaction between the host and pathogen.
  • Host lung injury triggers bacterial adaptation, including increased cytotoxin production.
  • Host-derived HS fragments modulate MRSA cytotoxin activity, contributing to disease severity.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
301
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
423
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
352
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
423
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K